12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aimix amlodipine besilate/irbesartan regulatory update

Dainippon said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Aimix amlodipine besilate/irbesartan to treat hypertension. Dainippon and Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507, Osaka, Japan) will co-market the...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >